Cost consequence analysis of using the Elecsys Anti-Müllerian Hormone Plus immunoassay as part of polycystic ovary syndrome assessment in the United Kingdom

Garay, U., Olziersky, A.M., Laven, J. et al. (4 more authors) (2024) Cost consequence analysis of using the Elecsys Anti-Müllerian Hormone Plus immunoassay as part of polycystic ovary syndrome assessment in the United Kingdom. In: ISPOR Europe 2024, 17-20 Nov 2024, Barcelona, Spain.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Author(s).

Dates:
  • Published: 18 November 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 22 Nov 2024 11:37
Last Modified: 22 Nov 2024 11:38
Published Version: https://www.ispor.org/heor-resources/presentations...
Status: Published
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics